EKTR News - Candlesense

Eureka Therapeutics Adds Stanford Liver Cancer Expert Dr. Samuel So to Scientific Advisory Board

EMERYVILLE, Calif.--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a clinical-stage biotechnology company pioneering safer and more effective T-cell therapies, today announced the appointment of Samue...

Is there any expected impact on the company's cash runway or need for additional capital raises? How might this news affect the stock's valuation multiples and forward‑looking earnings estimates? What potential regulatory implications could arise from accelerated HCC program milestones?

Board

20 days ago